Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1

[1]  B. Korf,et al.  NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Steinberg,et al.  Selumetinib in Children with Inoperable Plexiform Neurofibromas. , 2020, The New England journal of medicine.

[3]  T. Derlin,et al.  The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1 , 2020, PloS one.

[4]  S. Steinberg,et al.  Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: Growth analysis of plexiform neurofibromas and distinct nodular lesions. , 2020, Neuro-oncology.

[5]  Stephen H Bradley,et al.  Precocious puberty , 2020, BMJ.

[6]  J. Lai,et al.  Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespan , 2017, American journal of medical genetics. Part A.

[7]  S. Steinberg,et al.  Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. , 2014, Neuro-oncology.

[8]  S. Steinberg,et al.  Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I. , 2014, The Journal of pediatrics.

[9]  L. Kluwe,et al.  Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1 , 2012, Orphanet Journal of Rare Diseases.

[10]  Lisa J. Martin,et al.  Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1. , 2012, The Journal of pediatrics.

[11]  E. Quint,et al.  A rare vulvar manifestation of neurofibromatosis 1 in a teen. , 2009, Journal of pediatric and adolescent gynecology.

[12]  R. Friedrich,et al.  Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas , 2008, Journal of Medical Genetics.

[13]  E. Petty,et al.  The role of steroid hormones in the NF1 phenotype: Focus on pregnancy , 2008, American journal of medical genetics. Part A.

[14]  S. Steinberg,et al.  NF1 plexiform neurofibroma growth rate by volumetric MRI , 2007, Neurology.

[15]  Jeffrey Solomon,et al.  Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging. , 2004, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[16]  S. Bernasconi,et al.  Growth and pubertal disorders in neurofibromatosis type 1. , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[17]  L. Dugoff,et al.  Neurofibromatosis type 1 and pregnancy. , 1996, American journal of medical genetics.

[18]  J M Tanner,et al.  Variations in the Pattern of Pubertal Changes in Boys , 1970, Archives of disease in childhood.

[19]  J M Tanner,et al.  Variations in pattern of pubertal changes in girls. , 1969, Archives of disease in childhood.

[20]  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. , 1988, Archives of neurology.